Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Apr;4(1-2):33-8.

Fluctuating antibody response in a cohort of hepatitis C patients

Affiliations

Fluctuating antibody response in a cohort of hepatitis C patients

Said H S Al Dhahry et al. J Sci Res Med Sci. 2002 Apr.

Abstract

Objective: This project was designed to longitudinally study persons who had antibodies to hepatitis C virus (HCV) to characterise the serologic course of infection.

Methods: The subjects were 149 multitransfused patients (141 with thalassaemia major, 3 with thalassaemia intermedia, and 5 with sickle cell anaemia) who had been regularly followed up for 3 to 7 years. Sequential serum samples obtained semi-annually between January 1994 and January 2001 were tested, prospectively, by second or third generation HCV enzyme-linked immunosorbent assay (ELISA), followed by confirmatory recombinant immunoblot assay (RIBA-2 or RIBA-3).

Results: Of the 149 patients, 90 did not seroconvert to HCV, whereas 59 had detectable antibodies. On the basis of RIBA results in these 59 patients, 24 (41%) had persistent high antibody levels to structural and non structural HCV antigens, 11 (19%) had persistent low antibody levels, 17 (29%) showed fluctuating antibody levels, and in 5 patients (8%) there was a total or a partial disappearance of specific antibodies (seroreversion), mainly anti-core antibodies. Two patients (3%) had antibody responses that did not fit into any of these four categories. In patients with fluctuating antibody levels, there were periods ranging from 6 months to 2 years when anti-HCV antibodies could not be detected.

Conclusion: This study shows that the antibody response to HCV in patients who receive frequent blood transfusions is very variable. Individuals who exhibit intermittent seropositivity are a challenge to diagnosis.

Keywords: antibody response; hepatitis C virus; thalassaemia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Organization of hepatitis C virus genome and location of antigens licensed for diagnostic use.
Figure 2.
Figure 2.
Six and half years’ follow-up in a thalassaemic patient, showing persistently high levels of antibodies to hepatitis C virus antigens
Figure 3.
Figure 3.
Persistent low levels of antibodies to hepatitis C virus antigens in a patient who was followed over a six-year period
Figure 4.
Figure 4.
Fluctuating levels of antibodies to hepatitis C virus antigens in a atient over a six-year period of follow-up
Figure 5.
Figure 5.
Seroreversion in a patient infected by hepatitis C virus

Similar articles

Cited by

References

    1. Choo Q-L, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. Isolation of a cDNA clone derived from a blood-borne viral hepatitis genome. Science. 1989;244:359–362. - PubMed
    1. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet. 1994;344:1475–1479. - PubMed
    1. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis. N Eng J Med. 1995;332:1463–1466. - PubMed
    1. Alter HJ, Seef LB. Recovery, persistence, and sequelae in hepatitis C infection: a perspective on long-term outcome. Sem Liver Disease. 2000;20:17–35. - PubMed
    1. Herrine SK, Weinberg DS. Epidemiology of hepatitis C viral infection. Infect Med. 1999;16:111–117.

LinkOut - more resources